Elicio Therapeutics ELTX
NASDAQ ELTX
$1.63 +0.06 (+4.11%)
As of: Oct 21, 2026 · 10:50 AM EDT

Elicio Therapeutics (ELTX) Receivables (2023)

Updated

Elicio Therapeutics' Receivables was $9.68 million in Q1 2023.

Analysis

Elicio Therapeutics (ELTX) Receivables (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,132.46 Bn 1,101.04 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 614.45 Bn 532.98 Bn 17.26 Bn 19.05 Bn
3 AbbVie 503.76 Bn 476.87 Bn 12.70 Bn 13.82 Bn
4 Merck 367.67 Bn 322.05 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 298.09 Bn 262.08 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 261.81 Bn 235.50 Bn 12.86 Bn 15.68 Bn
7 Amgen 236.49 Bn 191.89 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 191.25 Bn 165.45 Bn 6.22 Bn 5.06 Bn
9 Pfizer 170.18 Bn 116.83 Bn 10.94 Bn 12.49 Bn
10 Elicio Therapeutics 31.47 Mn -46.16 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 9.68 Mn
API Access

Elicio Therapeutics Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=ELTX&period=max&api_key=YOUR_API_KEY